Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea

doi:10.3748/wjg.v20.i22.6932

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 22

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6634)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

388

WORD

258

HTML

3528

Figures (1-1)

261

Tables (1-4)

202

Sum=4637

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1042

Download

954

Sum=1996

Jun 14, 2014 (publication date) through Jan 31, 2025

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence-Based Medicine

World J Gastroenterol. Jun 14, 2014; 20(22): 6932-6938
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6932

Table 4 Helicobacter pylori eradication rates due to 14-d moxifloxacin triple therapy according to proton pump inhibitors

	Esomeprazole	Rabeprazole	P value¹
ITT analysis
% Eradication (ratio)	73.8% (127/172)	63.6% (28/44)	0.180
95%CI	66.8-79.8	48.9-76.2
PP analysis
% Eradication (ratio)	80.9% (127/157)	65.1% (28/43)	0.028
95%CI	74.0-86.3	50.2-77.6

¹Pearson's χ² test. ITT: Intention to treat; PP: Per protocol.

Citation: Kang KK, Lee DH, Oh DH, Yoon H, Shin CM, Park YS, Kim N, Jung HC. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea. World J Gastroenterol 2014; 20(22): 6932-6938
URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6932.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6932